Identification and Characterization of Nonalcoholic Fatty Liver Disease
| Autor: | Gabriel Chodick, Ilan Kochba, Oren Shibolet, Muriel Webb, Inbal Goldshtein, Nitsan Gal |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Comorbidity Disease Asymptomatic Body Mass Index Pharmacological treatment 03 medical and health sciences 0302 clinical medicine Non-alcoholic Fatty Liver Disease Risk Factors Internal medicine Nonalcoholic fatty liver disease Humans Mass Screening Medicine Hepatology business.industry Matched control Gastroenterology nutritional and metabolic diseases Patient Acceptance of Health Care medicine.disease digestive system diseases 030220 oncology & carcinogenesis Unselected population 030211 gastroenterology & hepatology medicine.symptom business Early phase Body mass index |
| Zdroj: | Clinical Gastroenterology and Hepatology. 18:1887-1889 |
| ISSN: | 1542-3565 |
| DOI: | 10.1016/j.cgh.2019.08.007 |
| Popis: | Nonalcoholic fatty liver disease (NAFLD) is characterized by substantial diagnostic and evaluation gaps with no systematic screening. Even recognized cases are undercoded because of the perceived benign nature of disease and current absence of approved pharmacologic treatment. NAFLD is often detected incidentally, particularly in the asymptomatic early phase. We doubled NAFLD detection via natural language processing of 1 million imaging reports combined with laboratory data from an unselected population. We describe NAFLD comorbidities and health care utilization as compared with age, sex, and body mass index matched control subjects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|